Google
English
French
German
Italian
Japanese
Portuguese
SpanishTrusted Resources: News & Meetings
Latest announcements and gatherings
Ultromics granted FDA Breakthrough Device Designation for AI-enhanced Cardiac Amyloidosis detection
Oxford, UK, April 26th, 2023 — Ultromics, a leader in the field of artificial intelligence-powered diagnostics for heart failure, has been granted FDA Breakthrough Device Status for its AI-enhanced platform for detecting cardiac amyloidosis.
The platform, EchoGo Amyloidosis, uses artificial intelligence to analyze echocardiograms and detect the presence of cardiac amyloidosis, a condition caused by deposits of abnormal proteins in the heart tissue, using only a single commonly acquired ultrasound view of the heart.
myBinderRelated Content
-
Echocardiography in Cardiac AmyloidosisEchocardiography is the most widely used...
-
Transthyretin Cardiac AmyloidosisPurpose of Review: Transthyretin (TTR)-...
-
Novel Strategies for the Diagnosis and Treatment of Cardiac AmyloidosisSystemic amyloidoses are rare, complex d...
-
Prevalence, Severity, and Prognostic Value of Sleep Apnea Syndromes in Cardiac AmyloidosisStudy Objectives: To assess prevalence,...
-
University of Maryland Medical CenterUniversity of Maryland Medical Center is...
-
Amyloidosis and the Heart: Patient InformationIn some patients with amyloidosis there ...
-
Prem Soman on Tc-99m PYP Scan to Diagnose ATTR Cardiac Amyloidosishttps://www.youtube.com/watch?v=EZCnGFiq...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
